Nohla Therapeutics Overview
- Year Founded
-
2015

- Status
-
Out of Business
- Employees
-
43

- Latest Deal Type
-
Out of Business
Nohla Therapeutics General Information
Description
Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical diseases. The company's products are based on a unique umbilical cord blood expansion platform, providing doctors the functional support of bone marrow in response to each patient's unique blood-production needs, without any requirement for HLA matching.
Contact Information
Website
www.nohlatherapeutics.comCorporate Office
- 1600 Fairview Avenue East
- Suite 100
- Seattle, WA 98102
- United States
Corporate Office
- 1600 Fairview Avenue East
- Suite 100
- Seattle, WA 98102
- United States
Nohla Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Out of Business | 01-Nov-2019 | Completed | Out of Business | |||
4. Early Stage VC (Series B) | 12-Jul-2018 | Completed | Clinical Trials - Phase 2 | |||
3. Grant | 28-Sep-2017 | Completed | Startup | |||
2. Early Stage VC (Series A) | 29-Nov-2016 | $43.5M | $64.5M | Completed | Startup | |
1. Corporate | 24-Dec-2015 | $21M | $21M | Completed | Startup |
Nohla Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A1 |
Nohla Therapeutics Comparisons
Industry
Financing
Details
Nohla Therapeutics Competitors (58)
One of Nohla Therapeutics’s 58 competitors is Gadeta, a Formerly VC-backed company based in Utrecht, Netherlands.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Gadeta | Formerly VC-backed | Utrecht, Netherlands | ||||
Phaxiam | Formerly VC-backed | Lyon, France | ||||
TScan Therapeutics | Formerly VC-backed | Waltham, MA | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
Kite Pharma | Formerly VC-backed | Santa Monica, CA |
Nohla Therapeutics Signals
Nohla Therapeutics FAQs
-
When was Nohla Therapeutics founded?
Nohla Therapeutics was founded in 2015.
-
Where is Nohla Therapeutics headquartered?
Nohla Therapeutics is headquartered in Seattle, WA.
-
What is the size of Nohla Therapeutics?
Nohla Therapeutics has 43 total employees.
-
What industry is Nohla Therapeutics in?
Nohla Therapeutics’s primary industry is Biotechnology.
-
Is Nohla Therapeutics a private or public company?
Nohla Therapeutics is a Private company.
-
What is Nohla Therapeutics’s current revenue?
The current revenue for Nohla Therapeutics is
. -
How much funding has Nohla Therapeutics raised over time?
Nohla Therapeutics has raised $120M.
-
Who are Nohla Therapeutics’s competitors?
Gadeta, Phaxiam, TScan Therapeutics, NexImmune, and Kite Pharma are some of the 58 competitors of Nohla Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »